Curant Health and the 2016 American College of Gastroenterology Annual Scientific Meeting
Curant Health and Johns Hopkins University present Project A.L.I.V.E. interim study results.
“Do you take your IBD medicine? Assessing the effect of a patient fulfillment model on medication adherence.”
Dr. Sharon Dudley-Brown, Principal Investigator, Assistant Professor of Medicine; Director of Clinical Services, Vickie Andros, PharmD. and Krystin Tran, PharmD.
Curant Health was proud to present study results to date with Dr. Sharon Dudley-Brown of Johns Hopkins at this year’s recent ACG 2016. First announced September 2014, Curant Health, provider of enhanced medication therapy management and specialty pharmacy services, is conducting a study with the Meyerhoff Inflammatory Bowel Disease Center of the Johns Hopkins University School of Medicine to “implement and evaluate the effectiveness of an Inflammatory Bowel Disease (IBD) Medication Therapy Management (MTM) patient fulfillment model compared to standard care in a large university hospital setting.”
The team is evaluating results at 30 days, 60 days, six months, nine months and 12 months from the initiation of the IBD MTM patient fulfillment model.
The study’s abstract is available here.
What are the study objectives?
To improve symptoms as measured by the Dudley IBD Symptom Questionnaire (DISQ) and quality of life as measured by the Short Inflammatory Bowel Disease Questionnaire (SIBDQ)
- To decrease hospital readmission rates for patients with IBD
- To improve adherence rates for IBD therapy
- To assess smoking rates among these patients with IBD
Why is it important to look at MTM and its effects on adherence rates for patients with IBD?
Increasingly recognized in the healthcare community is the absence of long-run reports on CD or UC. Therefore, data on Adverse Drug Events (ADE’s), hospital readmissions, and long-run adherence rates among these patients is currently very limited. An integrated MTM platform will allow for tackling these issues and evaluating the impact on IBD patients’ clinical outcomes. Read more from IBD News Today.
- Learnings from this year’s 340B Coalition Winter Conference February 16, 2017
Audits are one more opportunity to demonstrate the program is working well
We can only ...
- What we learned from J.P. Morgan Healthcare Conference 2017 January 24, 2017
Rumblings of imminent healthcare policy changes were not enough to distract attendees at this year’s ...
- We Honor our pharmacists on National Pharmacist Day January 11, 2017
In honor of National Pharmacist Day on January 12, we would like to take this ...
- What do you need to know about the 21st Century Cures Act? December 20, 2016
- It will add new tools to the life science toolbox.
More patients may begin to receive ...
- How to unlock a $41 billion pharmaceutical revenue opportunity December 13, 2016
From 2012-2015 there was a 13% increase in pharmaceutical revenue loss amounting to an estimated ...